SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001293971-22-000023
Filing Date
2022-04-05
Accepted
2022-04-05 07:03:50
Documents
14
Period of Report
2022-04-05
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K blue-20220405.htm   iXBRL 8-K 41878
2 EX-99.1 exhibit99120220405.htm EX-99.1 19372
6 image_0.jpg GRAPHIC 5923
  Complete submission text file 0001293971-22-000023.txt   215737

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blue-20220405.xsd EX-101.SCH 1923
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blue-20220405_lab.xml EX-101.LAB 24270
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blue-20220405_pre.xml EX-101.PRE 12652
8 EXTRACTED XBRL INSTANCE DOCUMENT blue-20220405_htm.xml XML 11260
Mailing Address 60 BINNEY STREET CAMBRIDGE MA 02142
Business Address 60 BINNEY STREET CAMBRIDGE MA 02142 339-499-9300
bluebird bio, Inc. (Filer) CIK: 0001293971 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35966 | Film No.: 22805167
SIC: 2836 Biological Products, (No Diagnostic Substances)